Apple continues focusing on blood-sugar tracking and more
Summary (By Apple Intelligence):
Apple conducted a trial of a blood sugar tracking app for prediabetic employees, aiming to educate them about food’s impact on blood sugar levels. The app may eventually be integrated into Apple’s non-invasive glucose tracker, which has been in development for over a decade.
Apple, aiming to expand its presence in the healthcare sector, conducted a trial this year of a blood sugar tracking application. The app, designed to assist individuals with prediabetes in managing their dietary choices and adopting lifestyle modifications, was piloted on a select group of employees. According to Bloomberg News, citing sources familiar with the matter, Apple’s broader strategy involves integrating blood-sugar features into its future health products.
Although Apple currently has no plans to release the app, there’s a possibility that it may eventually incorporate the technology into its non-invasive glucose tracker, a project that has been in development for over a decade.
During the trial, the participating employees underwent a blood test to confirm their prediabetic status. This means that while they currently don’t have diabetes, they are at risk of developing Type 2 diabetes. As part of the evaluation process, they actively monitored their blood sugar levels using various market-available devices and recorded glucose fluctuations in response to their food intake.
The primary objective of the system is to educate consumers about the impact of specific foods on blood sugar levels, with the aim of inspiring positive changes that could potentially prevent diabetes. For instance, if users recorded consuming pasta for lunch and subsequently experienced a rise in their blood sugar, they could be advised to modify their diet by either avoiding pasta or opting for a protein-rich alternative.
While the research conducted during this trial was not directly related to Apple’s ongoing efforts to develop a non-invasive glucose monitor, it could potentially contribute to the company’s understanding of how to manage this ambitious health initiative. The non-invasive glucose monitor represents a significant advancement in the fight against diabetes, as it aims to analyze a person’s blood without the need for a prick of the skin.